Bond Biosciences Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $12.1M

  • Investors
  • 5

Bond Biosciences General Information

Description

Developer of small molecule-based therapeutics designed to prevent and treat ion-related human diseases. The company offers non-absorbed oral therapeutics that bind excess ions in the gastrointestinal tract and inhibit their absorption to treat and prevent diseases caused by excess ions in the body, enabling patients and healthcare providers to manage ion-related diseases with convenient treatments and reduced reliance on invasive procedures.

Contact Information

Website
www.bond.bio
Formerly Known As
Fetterex Biopharma
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 170 English Landing Drive
  • Suite 201B
  • Parkville, MO 64152
  • United States
+1 (650)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
LOHAS & Wellness, HealthTech, Life Sciences
Corporate Office
  • 170 English Landing Drive
  • Suite 201B
  • Parkville, MO 64152
  • United States
+1 (650)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bond Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 05-Oct-2026 $12.1M Completed Clinical Trials - General
3. Later Stage VC (Series B) 25-Jan-2022 Completed Clinical Trials - General
2. Grant 01-Aug-2021 $299K $5M Completed Clinical Trials - General
1. Later Stage VC (Series A) 08-Dec-2020 $5M $5M Completed Clinical Trials - General
To view Bond Biosciences’s complete valuation and funding history, request access »

Bond Biosciences Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B
Series A
To view Bond Biosciences’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Bond Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of small molecule-based therapeutics designed to prevent and treat ion-related human diseases. The company off
Drug Discovery
Parkville, MO
3 As of 2026

Oxford, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Bond Biosciences Competitors (1)

One of Bond Biosciences’s competitors is Oxford Cancer Analytics, a Venture Capital-Backed company based in Oxford, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Oxford Cancer Analytics Venture Capital-Backed Oxford, United Kingdom
You’re viewing 1 of 1 competitors. Get the full list »

Bond Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Bond Biosciences Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
BioGenerator Ventures Venture Capital Minority
Emerald Bioventures Venture Capital Minority
Transhuman Capital Venture Capital Minority
National Institutes of Health Government
Collage Venture Partners Venture Capital Minority
To view Bond Biosciences’s complete investors history, request access »

Ready to get started?

Request a free trial

Bond Biosciences FAQs

  • When was Bond Biosciences founded?

    Bond Biosciences was founded in 2015.

  • Where is Bond Biosciences headquartered?

    Bond Biosciences is headquartered in Parkville, MO.

  • What is the size of Bond Biosciences?

    Bond Biosciences has 3 total employees.

  • What industry is Bond Biosciences in?

    Bond Biosciences’s primary industry is Drug Discovery.

  • Is Bond Biosciences a private or public company?

    Bond Biosciences is a Private company.

  • What is Bond Biosciences’s current revenue?

    The current revenue for Bond Biosciences is .

  • How much funding has Bond Biosciences raised over time?

    Bond Biosciences has raised $23.9M.

  • Who are Bond Biosciences’s investors?

    BioGenerator Ventures, Emerald Bioventures, Transhuman Capital, National Institutes of Health, and Collage Venture Partners have invested in Bond Biosciences.

  • Who are Bond Biosciences’s competitors?

    Oxford Cancer Analytics is a competitor of Bond Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process